Skip to main content

Current Treatment Modalities for Brain Tumor

Surgery, Radiation, and Chemotherapy

  • Chapter
Gene Therapy for Neurological Disorders and Brain Tumors

Part of the book series: Contemporary Neuroscience ((CNEURO))

Abstract

Because they are relatively refractory to current treatments, brain tumors are particularly promising candidates for genetic therapy. For many malignant brain tumors the side effects of even oncologically successful therapy still compromise quality of life. To illustrate the challenges faced, this chapter presents an outline of the current therapy of brain tumors in the context of their histopathological classification (1–3). Currently available therapeutic interventions for brain tumors include tumor biopsy for the purpose of diagnosis, and open operation for the reduction of tumor mass to the maximum extent consistent with preservation of neurologic function, chemotherapy, and radiation. This chapter reviews the application of these treatment modalities to intracranial tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kaye, A. H. and Laws Jr., E. R., eds. (1995) Brain Tumors: An Encyclopedic Approach. Churchill Livingstone, Edinburgh.

    Google Scholar 

  2. Tatter, S. B., Wilson, C. B., and Harsh IV, G. R. (1996) Neuroepithelial tumors of the adult brain, in Neurological Surgery, 4th ed. (Youmans, J. R., ed.). W. B. Saunders, Philadelphia, pp. 2612–2684.

    Google Scholar 

  3. Harsh IV, G. R., ed. (1996) Management of Cerebral Metastases. W. B. Saunders, Philadelphia, pp. 337–569.

    Google Scholar 

  4. Walker, A. E., Robins, M., and Weinfeld, F. D. (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35, 219–226.

    Article  PubMed  CAS  Google Scholar 

  5. Annegers, J. F., Schoenberg, B. S., Okazaki, H., and Kurland, L. T. (1981) Epidemiologic study of primary intracranial neoplasms. Arch. Neurol. 38, 217–219.

    Article  PubMed  CAS  Google Scholar 

  6. Green, J. R., Waggener, J. D., and Kriegsfeld, B. A. (1976) Classification and incidence of neoplasms of the central nervous system. Adv. Neurol. 15, 51–55.

    PubMed  CAS  Google Scholar 

  7. Helseth, A. and Mork, S. J. (1989) Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology. APMIS 97, 547–555.

    Article  PubMed  CAS  Google Scholar 

  8. Zimmerman, H. M. (1969) Brain tumors. Their incidence and classification in man and their experimental production, Ann. NYAcad. Sci. 159, 337–357.

    Article  Google Scholar 

  9. Gudmundsson, K. R. (1970) A survey of tumours of the central nervous system in Iceland during the 10-year period, 1954–1963. Acta Neurol. Scand. 46, 538–552.

    Article  Google Scholar 

  10. Teppo, L., Hakama, M., Hakulinen, T., Lehtonen, M., and Saxen, E. (1975) Cancer in Finland, 1953–1970. Incidence, mortality, prevalence. Acta Pathol. Microbiol. Scand [a] 252, Suppl. 54–55.

    Google Scholar 

  11. Boyle, P., Maisonneuve, P., Saracci, R., and Calum, S. M. (1990) Is the increased incidence of primary malignant brain tumor in the elderly real? J. Natl. Cancer Inst. 82, 1594–1596.

    Article  PubMed  CAS  Google Scholar 

  12. Greig, N. H., Ries, L. G., Yancik, R., and Rapoport, S. I. (1990) Increasing annual incidence of primary malignant brain tumors in the elderly. J. Natl. Cancer Inst. 82, 1621–1624.

    Article  PubMed  CAS  Google Scholar 

  13. Kleihues, P., Burger, P. C., and Scheithauer, B. W. (1993) Histologic Typing of Tumours of the Central Nervous System, 2nd ed. Springer-Verlag, Berlin.

    Book  Google Scholar 

  14. Russell, D. S. and Rubinstein, L. J. (1989) Pathology of Tumors of the Central Nervous System, 5th ed. Williams and Wilkins, Baltimore.

    Google Scholar 

  15. Chang, C. H., Housepian, E. M., and Herbert, C. (1969) An operative staging system and a megavoltage radio-therapeutic technique for cerebellar medulloblastomas. Radiology 93, 1351–1359.

    PubMed  CAS  Google Scholar 

  16. Ringertz, N. and Tola, J. H. (1950) Medulloblastoma. J. Neuropathol. Exp. Neurol. 9, 354–372.

    Article  PubMed  CAS  Google Scholar 

  17. Cavenee, W. K. (1992) Accumulation of genetic defects during astrocytoma progression. Cancer 70, 1788–1793.

    Article  PubMed  CAS  Google Scholar 

  18. Levine, A. J. and Schmidek, H. H., eds. (1993) Molecular Genetics of Nervous System Tumors. Wiley-Liss, New York.

    Google Scholar 

  19. von Deimling, A., Eibl, R. H., Ohgaki, H., et al. (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res. 52, 2987–2990.

    Google Scholar 

  20. Louis, D. N. (1994) The p53 gene and protein in human brain tumors. J. Neuropathol. Exp. Neurol. 53, 11–21.

    Article  PubMed  CAS  Google Scholar 

  21. von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Wiestler, O. D., and Seizinger, B. R. (1992) Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res. 52, 4277–4279.

    Google Scholar 

  22. Henson, J. W., Schnitker, B. L., Correa, K. M., et al. (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann. Neurol. 36, 714–721.

    Article  PubMed  CAS  Google Scholar 

  23. von Deimling, A., Louis, D. N., von Ammon, K., et al. (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J. Neurosurg. 77, 295–301.

    Article  Google Scholar 

  24. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B. (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355, 846–847.

    Article  PubMed  CAS  Google Scholar 

  25. Louis, D. N., von-Deimling, A., Chung, R. Y., et al. (1993) Comparative study of p53 gene and protein alterations in human astrocytic tumors. J. Neuropathol. Exp. Neurol. 52, 31–38.

    Article  PubMed  CAS  Google Scholar 

  26. von Deimling, A., von Ammon, K., Schoenfeld, D. A., Wiestler, O. D., Seizinger, B. R. and Louis, D. N. (1993) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol. 3, 19–26.

    Article  Google Scholar 

  27. Montine, T. J., Vandersteenhoven, J. J., Aguzzi, A., et al. (1994) Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 34, 674–679.

    Article  PubMed  CAS  Google Scholar 

  28. Coons, S. W., Johnson, P. C., Pearl, D. K., and Olafsen, A. G. (1994) Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. Neurosurgery 34, 680–687.

    Article  PubMed  CAS  Google Scholar 

  29. Pigott, T. J. D., Lowe, J. S., and Palmer, J. (1991) Statistical modeling in analysis of prognosis in glioblatoma multiforme. A study of clinical variables and Ki-67 immunoreactivity. Br. J. Neurosurg. 5, 61–66.

    Article  PubMed  CAS  Google Scholar 

  30. Schneider, J., Hofman, F. M., Apuzzo, M. L. J., and Hinton, D. R. (1992) Cytokines and immunoregulatory molecules in malignant glial neoplasms. J. Neurosurg. 77, 265–273.

    Article  PubMed  CAS  Google Scholar 

  31. Lazorthes, G. and Campan, L. (1974) Brain edema, Symptomatology, clinical forms, diagnosis and treatment, in Handbook of Clinical Neurology, vol. 16, Tumors of the Brain and Skull, Part I. ( Vinken, P. J. and Bruyn, G. W., eds.), North-Holland, Amsterdam, pp. 186–208.

    Google Scholar 

  32. Launay, M., Fredy, D., Merland, J. J., and Bories, J. (1977) Narrowing and occlusion of arteries by intracranial tumors. Neuroradiology 14, 117–126.

    Article  PubMed  CAS  Google Scholar 

  33. Zülch, K. J. (1986) Brain Tumors: Their Biology and Pathology, 3rd ed. Springer-Verlag, Berlin.

    Book  Google Scholar 

  34. Kelly, P. J., Daumas-Duport, C., Kispert, D. B., Kall, B. A., Scheithauer, B. W., and Illig, J. J. (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J. Neurosurg. 66, 865–874.

    Article  PubMed  CAS  Google Scholar 

  35. Aronen, H. J., Gazit, I. E., Louis, D. N., et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191, 41–51.

    PubMed  CAS  Google Scholar 

  36. Preul, M. C., Caramanos, Z., Collins, D. L., Villemure, J. G., Leblanc, R., and Olivier, A. (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton. Nature Med. 2, 323–325.

    Article  PubMed  CAS  Google Scholar 

  37. Barker F. G. Z., Chang, S. M., Valk, P. E., Pounds, T. R., and Prados, M. D. (1997) 18Fluorodeoxyglucose uptake and survival of patients with suspected. Cancer 79, 115–126.

    Google Scholar 

  38. De, W. O., Levivier, M., Violon, P., Salmon, I., Damhaut, P., and Wilder Jr., D. (1996) Prognostic value positron emission tomography with [18F]flouro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 39, 470–476.

    Google Scholar 

  39. Galicich, J. H., French, L., and Melby, J. C. (1961). Use of dexamethasone in treatment of cerebral edema associated with brain tumors. Lancet 1, 46–53.

    Google Scholar 

  40. Leiguarda, R., Sierra, J., Pardal, C., and Zambrano, D. (1985) Effect of large doses of methylprednisolone on supratentorial intracranial tumors. A clinical and CAT scan evaluation. Eur. Neurol. 24, 23–32.

    Article  PubMed  CAS  Google Scholar 

  41. Wilson, C. B., Barker, M., and Hoshino, T., et al. (1972) Steroid induced inhibition of growth in glial tumor: a kinetic analysis, in Steroids and Brain Edema ( Reulen, H. J. and Schurmann, K., eds.), Springer-Verlag, Berlin, pp. 95–100.

    Chapter  Google Scholar 

  42. Paoletti, P., Robustelli della Cuna, G., Knerich, R., and Strada, M. R. (1978) Multidisciplinary treatment for central nervous system tumors with nitrosourea compounds. Acta Neurochir. 41, 287–299.

    Article  PubMed  CAS  Google Scholar 

  43. Marshall, L. F., Jennett, B., and Langfit, T. W. (1974) Needle biopsy for the diagnosis of malignant glioma. JAMA 228, 1417–1418.

    Article  PubMed  CAS  Google Scholar 

  44. Ojemann, R. G. (1992) Management of acoustic neuromas (vestibular Schwannomas) Clin. Neurosurg. 40, 498–535.

    Google Scholar 

  45. Ojemann, R. G. (1992) Management of cranial and spinal meningiomas. Clin. Neurosurg. 40, 321–383.

    Google Scholar 

  46. Davidoff, L. M. (1966) Some random thoughts on the astrocytomas. Bull. NYAcad. Med. 42, 85–99.

    CAS  Google Scholar 

  47. Leibel, S. A., Sheline, G. E., Wara, W. M., Boldrey, E. B., and Nielsen, S. L. (1975) The role of radiation therapy in the treatment of astrocytomas. Cancer 35, 1551–1557.

    Article  PubMed  CAS  Google Scholar 

  48. Philippon, J. H., Clemenceau, S. H., Fauchon, F. H., and Foncin, J. F. (1993) Supratentorial low-grade astrocytomas in adults. Neurosurgery 32, 554–559.

    Article  PubMed  CAS  Google Scholar 

  49. Piepmeier, J., Christopher, S., Spencer, D., et al. (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38, 872–879.

    Article  PubMed  CAS  Google Scholar 

  50. Laws Jr., E. R., Taylor, W. F., Clifton, M. B., and Okazaki, H. (1984) Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J. Neurosurg. 61, 665–673.

    Article  PubMed  Google Scholar 

  51. Nazzaro, J. M. and Neuwelt, E. A. (1990) The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J. Neurosurg. 73, 331–344.

    Article  PubMed  CAS  Google Scholar 

  52. Mullan, S. (1975) Surgery of brain tumors, in Handbook of Clinical Neurology, vol. 18, Tumors of the Brain and Skull, Part III. ( Vinken, P. J. and Bruyn, G. W., eds.), North-Holland, Amsterdam, pp. 471–480.

    Google Scholar 

  53. Devaux, B. C., O’Fallon, J. R., and Kelly, P. J. (1993) Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J. Neurosurg. 78, 767–775.

    Article  PubMed  CAS  Google Scholar 

  54. Winger, M. J., Macdonald, D. R., and Cairncross, J. G. (1989) Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J. Neurosurg. 71, 487–493.

    Article  PubMed  CAS  Google Scholar 

  55. Ammirati, M., Vick, N., Liao, Y. L., Ciric, I., and Mikhael, M. (1987) Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21, 201–206.

    Article  PubMed  CAS  Google Scholar 

  56. Vecht, C. J., Avezaat, C. J. J., van Putten, W. L. J., Eijkenboom, W. M. H., and Stefanko, S. Z. (1990) The influence of extent of surgery on the neurological function and survival in maligant glioma. A retrospective analysis in 243 patients. J. Neurol. Neurosurg. Psychiatry 53, 466–476.

    Article  PubMed  CAS  Google Scholar 

  57. Quigley, M. R. and Maroon, J. C. (1991) The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas. Neurosurgery 29, 385–389.

    Article  PubMed  CAS  Google Scholar 

  58. Prados, M. D., Gutin, P. H., Phillips, T. L., et al. (1992) Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int. J. Radiat. Oncol. Biol. Phys. 23, 3–8.

    Article  PubMed  CAS  Google Scholar 

  59. Wood, J. R., Green, S. B., and Shapiro, W. R. (1988) The prognostic importance of tumor size in malignant gliomas. A computed tomographic scan study by the Brain Tumor Cooperative Group. J. Clin. Oncol. 6, 338–343.

    PubMed  CAS  Google Scholar 

  60. Patchell, R. A., Tibbs, P. A., Walsh, J. W., et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 322, 494.

    Article  PubMed  CAS  Google Scholar 

  61. Simpson, J. R., Horton, J., Scott, C., et al. (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26, 239–244.

    Article  PubMed  CAS  Google Scholar 

  62. Curran Jr., W. J., Scott, C. B., Horton, J., et al. (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl. Cancer Inst. 85, 704–710.

    Article  PubMed  Google Scholar 

  63. Earle, K. M., Rentschler, E. H., and Snodgrass, S. R. (1957) Primary intracranial neoplasms. Prognosis and classification of 513 verified cases. J. Neuropathol. Exp. Neurol. 16, 321–331.

    Article  PubMed  CAS  Google Scholar 

  64. Jelsma, R. and Bucy, P. C. (1969) Glioblastoma multiforme: its treatment and some factors affecting survival. Arch. Neurol. 20, 161–171.

    Article  PubMed  CAS  Google Scholar 

  65. Salcman, M. (1980) Survival in glioblastoma. Historical perspective. Neurosurgery 7, 435–439.

    Article  PubMed  CAS  Google Scholar 

  66. Levin, V. A., Crafts, D. C., Norman, D. M., Hoffer, P. B., Spire, J. P., and Wilson, C. B. (1977) Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J. Neurosurg. 47, 329–335.

    Article  PubMed  CAS  Google Scholar 

  67. Harsh, G. R., IV, Levin, V. A., Gutin, P. H., Seager, M., Silver, P., and Wilson, C. B. (1987) Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21, 615–621.

    Article  PubMed  Google Scholar 

  68. Salcman, M., Kaplan, R. S., Ducker, T. B., Abdo, H., and Montgomery, E. (1982) Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery 10, 454–463.

    Article  PubMed  CAS  Google Scholar 

  69. Chandler, K. L., Prados, M. D., Malec, M., and Wilson, C. B. (1993) Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32, 716–720.

    Article  PubMed  CAS  Google Scholar 

  70. Brem, H., Mahaley, M. S., Vick, N. A., et al. (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg. 74, 441–446.

    Article  PubMed  CAS  Google Scholar 

  71. Walter, K. A., Tamargo, R. J., Olivi, A., Burger, P. C., and Brem, H. (1995) Intratumoral chemotherapy. Neurosurgery 37, 1128–1145.

    PubMed  CAS  Google Scholar 

  72. Sano, K. (1983) Integrative treatment of gliomas Clin. Neurosurg. 30, 93–124.

    PubMed  CAS  Google Scholar 

  73. Shapiro, W. R. (1982) Treatment of neuroectodermal brain tumors. Ann. Neurol. 12, 231–237.

    Article  PubMed  CAS  Google Scholar 

  74. Little, J. B. (1968) Cellular effects of ionizing radiation. N. Engl. J. Med. 278, 308–315.

    Article  Google Scholar 

  75. Bloom, H. J. (1982) Intracranial tumors. Response and resistance to therapeutic endeavors, 1970–1980. Int. J. Radiat. Oncol. Biol. Phys. 8, 1083–1113.

    Article  PubMed  CAS  Google Scholar 

  76. Walker, M. D., Alexander Jr., E., Hunt, W. E., et al. (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg. 49, 333–343.

    Article  PubMed  CAS  Google Scholar 

  77. Walker, M. D., Strike, T. A., and Sheline, G. E. (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 5, 1725–1731.

    Article  PubMed  CAS  Google Scholar 

  78. Salazar, O. M., Rubin, P., Feldstein, M. L., and Pizzutiello, R. (1979) High dose radiation therapy in the treatment of malignant gliomas. Final report. Int. J. Radiat. Oncol. Biol. Phys. 5, 1733–1740.

    Article  PubMed  CAS  Google Scholar 

  79. Hoppe-Hirsch, E., Renier, D., Lelloch-Tubiana, A., Sainte-Rose, C., Pierre-Kahn, A., and Hirsch, J. F. (1990) Medulloblastoma in childhood. Progressive intellectual deterioration. Child’s Nerv. Syst. 6, 60–65.

    Article  PubMed  CAS  Google Scholar 

  80. Cairncross, J. G., Kim, J.-H., and Posner, J. B. (1980) Radiation therapy for brain metastases. Ann. Neurol. 7, 529.

    Article  PubMed  CAS  Google Scholar 

  81. Zimm, S., Wampler, G. L., Stablein, D., Hazra, T., and Young, H. F. (1981) Intracerebral metastases in solid-tumor patients. Natural history and results of treatment. Cancer 48, 384–394.

    Article  PubMed  CAS  Google Scholar 

  82. Kramer, S. (1968) The hazards of therapeutic irradiation of the central nervous system. Clin. Neurosurg. 15, 301–318.

    PubMed  CAS  Google Scholar 

  83. Sheline, G. E., Wara, W. M., and Smith, V. (1980) Therapeutic irradiation and brain injury. Int. J. Radiat. Oncol. Biol. Phys. 6, 1215–1228.

    Article  PubMed  CAS  Google Scholar 

  84. Burger, P. C., Mahaley Jr., M. S., Dudka, L., and Vogel, F. S. (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas. A postmortem study of 25 cases. Cancer 44, 1256–1272.

    Article  PubMed  CAS  Google Scholar 

  85. Patronas, N. J., DiChiro, G. D., Kufta, C., et al. (1985) Prediction of survival in glioma patients by means of positron emission tomography. J. Neurosurg. 62, 816–827.

    Article  PubMed  CAS  Google Scholar 

  86. Alexander III, E., Loeffler, J. S., Schwartz, R. B., et al. (1993) Thallium-201 technetium-99m HMPAO single-photon emission computed tomography (SPECT) imaging for guiding stereotactic craniotomies in heavily irradiated malignant glioma patients. Acta Neurochir. 122, 215–217.

    Article  PubMed  Google Scholar 

  87. Rizzoll, H. V. and Pagnanelli, D. M. (1984) Treatment of delayed radiation necrosis of the brain. A clinical observation. J. Neurosurg. 60, 589–594.

    Article  Google Scholar 

  88. Edwards, M. S. and Wilson, C. B. (1980) Treatment of radiation necrosis, in Radiation Necrosis of the Brain ( Kagan, A. R. and Gilbert, H. A., eds.), Raven, New York, pp. 129–143.

    Google Scholar 

  89. Hohwieler, M. L., Lo, T. C., Silverman, M. L., and Freidberg, S. R. (1986) Brain necrosis after radiotherapy for primary intracerebral tumor. Neurosurgery 18, 67–74.

    Article  PubMed  CAS  Google Scholar 

  90. Shaw, E. G., Daumas-Duport, C., Scheithauer, B. W., et al. (1989) Radiation therapy in the management of low-grade supratentorial astrocytomas. J. Neurosurg. 70, 853–861.

    Article  PubMed  CAS  Google Scholar 

  91. Shapiro, W. R., Green, S. B., Burger, P. C., et al. (1989) Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group trial 8001. J. Neurosurg. 71, 1–9.

    Article  PubMed  CAS  Google Scholar 

  92. Fulton, D. S., Urtasun, R. C., Shin, K. H., et al. (1984) Misonidazole combined with hyper-fractionation in the management of malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 10, 1709–1712.

    Article  PubMed  CAS  Google Scholar 

  93. Urtasun, R. C., Band, P., Chapman, J. D., Feldstein, M. L., Mielke, B., and Fryer, C. (1976) Radiation and high dose metronidazole in supratentorial glioblastomas. N. Engl. J. Med. 294, 1364–1367.

    Article  PubMed  CAS  Google Scholar 

  94. Kapp, D. W., Wagner, F. C., and Lawrence, R. (1982) Glioblastoma multiforme. Treated by large dose fraction irradiation and metronidazole. Int. J. Radiat. Oncol. Biol. Phys. 8, 351–355.

    Article  PubMed  CAS  Google Scholar 

  95. Shin, K. H., Urtasun, R. C., Fulton, D., et al. (1985) Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. Cancer 56, 758–760.

    Article  PubMed  CAS  Google Scholar 

  96. Urtasun, R., Feldstein, M. L. and Partington, J., et al. (1982) Radiation and nitromidazoles in supratentorial high grade gliomas: a second clinical trial. Br. J. Cancer 46, 101–108.

    Article  PubMed  CAS  Google Scholar 

  97. Goffman, T. E., Dachowski, L. J., Bobo, H., et al. (1992) Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiform treated with iododeoxyuridine and hyperfractionated irradiation. J. Clin. Oncol. 10, 264–268.

    PubMed  CAS  Google Scholar 

  98. Olson, J. J., Shelley, C., Orr, K., DeLaney, T., and Oldfield, E. H. (1992) The cerebral radioprotective effect of alternative barbiturates to pentobarbital. Neurosurgery 30, 720–723.

    Article  PubMed  CAS  Google Scholar 

  99. Shaw, C. M., Sumi, S. M., Alvord, E. C., Jr., Gerdes, A. J., Spence, A., and Parker, R. G. (1978) Fast neutron irradiation of glioblastoma multiforme. J. Neurosurg. 49, 1–12.

    Article  PubMed  CAS  Google Scholar 

  100. Hatanaka, H. (1988) Experience of boron-neutron capture therapy for malignant braintumours—with special reference to the problems of postoperative CT follow-ups. Acta Neurochir. 42, Suppl. 187–192.

    Google Scholar 

  101. Madoc-Jones, H., Wazer, D. E., Zamenhof, R. G., Harling, O. K., and Bernard Jr., J., A. (1990) Clinical considerations for neutron capture therapy of brain tumors. Basic Life Sci. 54, 23–35.

    PubMed  CAS  Google Scholar 

  102. Hochberg, F. H. and Pruitt, A. (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30, 907–991.

    Article  PubMed  CAS  Google Scholar 

  103. Loeffler, J. S., Alexander, E. 3., Shea, W. M., et al. (1992) Radiosurgery as part of the initial management of patients with malignant gliomas. J. Clin. Oncol. 10, 1379–1385.

    PubMed  CAS  Google Scholar 

  104. Tatter, S. B., Butler, W. E., and Chapman, P. H. (1997) Technical and clinical aspects of proton-beam radiosurgery, in Textbook of Stereotactic and Functional Neurosurgery (Gildenberg, P. L. and Tasker, R.,eds.), McGraw-Hill, New York, in press.

    Google Scholar 

  105. Pollock, B. E., Lunsford, L. D., Kondziolka, D., Flickinger, J. C., and Bissonette, D. J. (1995) Outcome analysis of acoustic neuroma management. A comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 36, 215–224.

    Article  PubMed  CAS  Google Scholar 

  106. Duma, C. M., Lunsford, L. D., Kondziolka, D., Harsh 4, G., and Flickinger, J. C. (1993) Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurgery. Neurosurgery 32, 699–704.

    Article  PubMed  CAS  Google Scholar 

  107. Gill, S. (1995) Radiosurgery for brain tumours: is there a proven benefit? Br. J. Neurosurg. 9, 123–125.

    Article  PubMed  CAS  Google Scholar 

  108. Pollock, B. E., Kondziolka, D., Flickinger, J. C., Maitz, A., and Lunsford, L. D. (1993) Preservation of cranial nerve function after radiosurgery for nonacoustic schwannomas. Neurosurgery 33, 597–601.

    Article  PubMed  CAS  Google Scholar 

  109. Alexander, E., III, Moriarty, T. M., Davis, R. B., et al. (1995) Stereotactic radiosurgery for the definitive non-invasive treatment of brain metastases. J. Natl. Cancer Inst. 87, 34–40.

    Article  PubMed  Google Scholar 

  110. Flickinger, J. C., Kondziolka, D., and Lunsford, L. D., et al. (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 28, 797–802.

    Article  PubMed  CAS  Google Scholar 

  111. Kjellberg, R. N., Hanamura, T., Davis, K. R., Lyons, S. L., and Adams, R. D. (1983) Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N. Engl. J. Med. 309, 269–274.

    Article  PubMed  CAS  Google Scholar 

  112. Loeffler, J. S., Alexander 3, E., Wen, P. Y., et al. (1990) Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J. Natl. Cancer Inst. 82, 1918–1921.

    Article  PubMed  CAS  Google Scholar 

  113. Prados, M. D., Gutin, P. H., Phillips, T. L., et al. (1992) Interstitial brachytherapy for newly diagnosed patients with malignant glioma. The UCSF experience. Int. J. Radiat. Oncol. Biol. Phys. 24, 593–597.

    Article  PubMed  CAS  Google Scholar 

  114. Gutin, P. H., Prados, M. D., Phillips, T. L., et al. (1991) External irradiation followed by an interstitial high activity iodine-125 implant “boost” in the initial treatment of malignant gliomas. NCOG study 6G-82–2. Int. J. Radiat. Oncol. Biol. Phys. 21, 601–606.

    Article  PubMed  CAS  Google Scholar 

  115. Scharfen, C. O., Sneed, P. K., Wara, W. M., et al. (1992) High activity iodine-125 interstitial implant for gliomas. Int. J. Radiat. Oncol. Biol. Phys. 24, 583–591.

    Article  PubMed  CAS  Google Scholar 

  116. Leibel, S. A., Gutin, P. H., Wara, W. M., et al. (1989) Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 17, 1129–1139.

    Article  PubMed  CAS  Google Scholar 

  117. Florell, R. C., Macdonald, D. R., Irish, W. D., et al. (1992) Selection bias, survival, and brachytherapy for glioma. J. Neurosurg. 76, 179–183.

    Article  PubMed  CAS  Google Scholar 

  118. Pollock, B. E., Lunsford, L. D., Kondziolka, D., Levine, G., and Flickinger, J. C. (1995) Phosphorus-32 intracavitary irradiation of cysytic craniopharyngiomas. Current technique and long term results. Int. J. Radiat. Oncol. Biol. Phys. 33, 437–446.

    Article  PubMed  CAS  Google Scholar 

  119. Van den Berge, J. H., Blaauw, G., Breeman, W. A., Rahmy, A., and Wijngaarde, R. (1992) Intracavitary brachytherapy of cystic craniopharyngiomas. J. Neurosurg. 77, 545–550.

    Article  PubMed  Google Scholar 

  120. Fig. L. M., Shapiro, B., and Taren, J. (1992) Distribution of [32P]-chromic phosphate colloid in cystic braintumors. Stereotact. Funct. Neurosurg. 59, 166–168.

    Article  Google Scholar 

  121. Hood, T. W., Shapiro, B., and Taren, J. A. (1987) Treatment of cystic astrocytomas with intracavitary phosphorus 32. Acta Neurochir. 39, Suppl. 34–37.

    Google Scholar 

  122. Chatel, M., Lebrun, C., and Frenay, M. (1993) Chemotherapy and immunotherapy in adult maligant gliomas. Curr. Opinion Oncol. 5, 464–473.

    Article  CAS  Google Scholar 

  123. Edwards, M. S., Levin, V. A., and Wilson, C. B. (1980) Brain tumor chemotherapy. An evaluation of agents in current use for phase II and III trials. Cancer Treatment Rep. 64, 1179–1205.

    CAS  Google Scholar 

  124. Fine, H. A., Dear, K. B., Loeffler, J. S., Black, P. M., and Canellos, G. P. (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71, 2585–2597.

    Article  PubMed  CAS  Google Scholar 

  125. Lesser, G. J. and Grossman, S. A. (1993) The chemotherapy of adult primary brain tumors. Cancer Treatment Rev. 19, 261–281.

    Article  CAS  Google Scholar 

  126. Walker, M. D., Green, S. B., Byar, D. P., et al. (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303, 1323–1329.

    Article  PubMed  CAS  Google Scholar 

  127. Jeremic, B., Jovanovic, D., Djuric, L., Jevremovic, S., and Mijatovic, L. (1992) Advantage of postradiotherapy chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas. NCOG 6G61 final report. J. Chemother. 4, 123–126.

    PubMed  CAS  Google Scholar 

  128. Levin, V. A., Silver, P., Hannigan, J., et al. (1990) Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int. J. Radiat. Oncol. Biol. Phys. 18, 321–324.

    Article  PubMed  CAS  Google Scholar 

  129. Glass, J., Hochberg, F. H., Gruber, M. L., Louis, D. N., Smith, D., and Rattner, B. (1992) The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J. Neurosurg. 76, 741–745.

    Article  PubMed  CAS  Google Scholar 

  130. Kim, L., Hochberg, F. H., Thornton, A. F., Harsh 4, G., Patel, H., and Finkelstein, D. (1996) Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III. J. Neurosurg. 85, 602–607.

    Article  PubMed  CAS  Google Scholar 

  131. Cairncross, J. G., George, E. D., MacDonald, D. R., and Ramsay, D. A. (1992) Aggressive oligodendroglioma. A chemosensitive tumor. Neurosurgery 31, 78–82.

    Article  PubMed  CAS  Google Scholar 

  132. Mahaley, M. S., Jr., Urso, M. B., Whaley, R. A., et al. (1985) Immunobiology of primary intracranial tumors. Part 10. Therapeutic efficacy of interferon in the treatment of recurrent gliomas. J. Neurosurg. 63, 719–725.

    Article  PubMed  Google Scholar 

  133. Evans, A. E., Jenkin, R. D., Sposto, R., et al. (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J. Neurosurg. 72, 572–582.

    Article  PubMed  CAS  Google Scholar 

  134. Packer, R. J., Sutton, L. N., Elterman, R., et al. (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J. Neurosurg. 81, 690–698.

    Article  PubMed  CAS  Google Scholar 

  135. Kovnar, E. H., Kellie, S. J., Horowitz, M. E., et al. (1990) Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. J. Clin. Oncol. 8, 330–336.

    PubMed  CAS  Google Scholar 

  136. Duffner, P. K., Horowitz, M. E., Krischer, J. P., et al. (1993) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. N. Engl. J. Med. 328, 1725–1731.

    Article  PubMed  CAS  Google Scholar 

  137. Lesser, G. J. (1996) Chemotherapy of cerebral metastases from solid tumors. Neurosurg. Clin. N. Am. 7, 527–536.

    PubMed  CAS  Google Scholar 

  138. Origitano, T. C. and Reichman, O. H. (1993) Photodynamic therapy for intracranial neoplasms: development of an image-based computer-assisted protocol for photodynamic therapy of intracranial neoplasms. Neurosurgery 32, 587–595.

    Article  PubMed  CAS  Google Scholar 

  139. Iacono, R. P., Stea, B., Lulu, B. A., Cetas, T., and Cassady, J. R. (1992) Template-guided stereotactic implantation of malignant brain tumors for interstitial thermoradiotherapy. Stereotact. Funct. Neurosurg. 59, 199–204.

    Article  PubMed  CAS  Google Scholar 

  140. Levin, V. A., Prados, M. D., Yung, W. K., Gleason, M. J., Ictech, S., and Malec, M. (1992) Treatment of recurrent gliomas with eflornithine. J. Natl. Cancer Inst. 84, 1432–1437.

    Article  PubMed  CAS  Google Scholar 

  141. Hall, W. A. and Fodstad, O. (1992) Immunotoxins and central nervous system neoplasia. J. Neurosurg. 76, 1–12.

    Article  PubMed  CAS  Google Scholar 

  142. Kornblith, P. K., Welch, W. C., and Bradley, M. K. (1993) The future of therapy for glioblastoma. Surg. Neurol. 39, 538–543.

    Article  PubMed  CAS  Google Scholar 

  143. Couldwell, W. T., Weiss, M. H., DeGiorgio, C. M., et al. (1993) Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 32, 485–489.

    Article  PubMed  CAS  Google Scholar 

  144. Vertosick Jr., F. T., Selker, R. G., Pollack, I. F., and Arena, V. (1992) The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy. Preliminary results in a series of “failed” patients. Neurosurgery 30, 897–902.

    Article  PubMed  Google Scholar 

  145. Kim, K. J., Li, B., Winer, J., et al. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841–844.

    Article  PubMed  CAS  Google Scholar 

  146. Fischer, S. P., Lindermuth, J., Hash, C., and Shenkin, H. A. (1985) Levamisole in the treatment of glioblastoma multiforme. J. Surg. Oncol. 28, 214–216.

    Article  PubMed  CAS  Google Scholar 

  147. Lillehei, K. O., Mitchell, D. H., Johnson, S. D., McCleary, E. L., and Kruse, C. A. (1991) Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy. Neurosurgery 28, 16–23.

    Article  PubMed  CAS  Google Scholar 

  148. Mahaley, M. S., Jr., Steinbok, P., Aronin, P., Dudka, L., and Zinn, D. (1981) Immunobiology of primary intracranial tumors. Part 4. Levamisole as an immune stimulant in patients and in the ASV glioma model. J. Neurosurg. 54, 220–227.

    Article  PubMed  Google Scholar 

  149. Steinbok, P., Thomas, J. P., and Grossman, L., et al. (1984) Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A Phase I study. J. Neurooncol. 2, 147–51.

    Article  PubMed  CAS  Google Scholar 

  150. Mahaley Jr., M. S., Bigner, D. D., Dudka, L. F., et al. (1983) Immunobiology of primary intracranial tumors. Part 7. Active immunization of patients with anaplastic human glioma cells. A Pilot Study. J. Neurosurg. 59, 201–207.

    Article  PubMed  Google Scholar 

  151. Yung, W. K., Prados, M., Levin, V. A., et al. (1991) Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study. J. Clin. Oncol. 9, 1945–1949.

    PubMed  CAS  Google Scholar 

  152. von Wild, K. R. and Knocke, T. H. (1991) The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma-a phase II study. Neurosurg. Rev. 14, 203–213.

    Article  Google Scholar 

  153. Elliott, L.H., Brooks, W. H., and Roszman, T. L. (1992) Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor. J. Neurooncol. 14, 1–7.

    Article  PubMed  CAS  Google Scholar 

  154. Holladay, F. P., Heitz, T., and Wood, G. W. (1992) Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells. J. Neurosurg. 77, 757–762.

    Article  PubMed  CAS  Google Scholar 

  155. Hochberg, F. H. and Slotnick, B. (1980) Neuropsychologic impairment in astrocytoma survivors. Neurology 30, 172–177.

    Article  PubMed  CAS  Google Scholar 

  156. Archibald, Y. M., Lunn, D., Ruttan, L. A., et al. (1994) Cognitive functioning in long-term survivors of high-grade gliomas. J. Neurosurg. 80, 247–253.

    Article  PubMed  CAS  Google Scholar 

  157. Shapiro, W. R. and Young, R. F. (1976) Treatment of malignant glioma. Arch. Neurol. 33, 494–500.

    Article  PubMed  CAS  Google Scholar 

  158. Norman, D., Enzmann, D. R. and Levin, V. A., et al. (1976) Computed tomography in the evaluation of malignant glioma before and after therapy. Radiology 121, 85–88.

    PubMed  CAS  Google Scholar 

  159. Salcman, M., Levine, H., and Roa, K. (1981) Value of sequential computed tomography in the multimodality treatment of glioblastoma multiforme. Neurosurgery 8, 15–19.

    Article  PubMed  CAS  Google Scholar 

  160. Burger, P. C., Kamenar, E., and Schold, S. C. J. (1981) Encephalomyelopathy following high-dose BCNU therapy. Cancer 48, 1318–1327.

    Article  Google Scholar 

  161. Lieberman, A. N., Foo, S. H., Ransohoff, J., et al. (1982) Long-term survival among patients with malignant brain tumors. Neurosurgery 10, 450–453.

    Article  PubMed  CAS  Google Scholar 

  162. Poisson, M., Hauw, J. J., Mashaly, R., Duyckaerts, C., and Escourolle, R. (1983) Status spongiosus in the course of treatment of malignant gliomas. J. Neur ncol. 1, 29–37.

    CAS  Google Scholar 

  163. Seiler, R. W. (1980) Late results of multimodality therapy of high grade supratentorial astrocytomas. Surg. Neurol. 15, 88–91.

    Article  Google Scholar 

  164. Neuwelt, E. A., Howieson, J., Frenkel, E. P., et al. (1986) Therapeutic efficacy of multi-agent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery 19, 573–582.

    Article  PubMed  CAS  Google Scholar 

  165. Savaraj, N., Lu, K., and Feun, L. (1983) Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,1-bis (carboelhoxyamlno) 1,4-benzoquinone (AZQ, NSC-182986). J. Neurooncol. 1, 15–19.

    Article  PubMed  CAS  Google Scholar 

  166. Schold, S. C., Jr., Friedman, H. S., Bjornosson, T. D., et al. (1984) Treatment of patients with recurrent primary brain tumors with AZQ. Neurology 34, 615–619.

    Article  PubMed  Google Scholar 

  167. Schold, S. C., Jr., Herndon, J. E., Burger, P. C., et al. (1993) Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma. J. Clin. Oncol. 11, 77–83.

    PubMed  Google Scholar 

  168. Kroin, J. S. and Penn, R. O. (1982) Intracerebral chemotherapy. Chronic microinfusion of cisplatin. Neurosurgery 10, 349–354.

    Article  PubMed  CAS  Google Scholar 

  169. Bigner, D. D. (1981) Biology of gliomas. Potential clinical implications of glioma cellular heterogeneity. Neurosurgery 9, 320–326.

    Article  PubMed  CAS  Google Scholar 

  170. Kornblith, P. L., Smith, B. H., and Leonard, L. A. (1981) Response of cultured human brain tumors to nitrosoureas: correlation with clinical data. Cancer 47, 255–265.

    Article  PubMed  CAS  Google Scholar 

  171. Rosenblum, M. L., Gerosa, M. A., Wilson, C. B., et al. (1983) Stem cell studies of human malignant brain tumors. Part I: Development of the stem cell assay and its potential. J. Neurosurg. 58, 170–176.

    Article  PubMed  CAS  Google Scholar 

  172. Bodell, W. J., Aida, T., Berger, M. S., and Rosenblum, M. L. (1986) Increased repair of 06-alkylguanine DNA adjuncts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1,3-bis (2-chloroethyl)-1-nitrosurea. Carcinogenesis 7, 879–884.

    Article  PubMed  CAS  Google Scholar 

  173. Hochberg, F. H., Parker, L. M., Takvorian, T., Canellos, G. P., and Zervas, N. T. (1981) High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J. Neurosurg. 54, 455–460.

    Article  PubMed  CAS  Google Scholar 

  174. Kapp, J. P. and Vance, R. B. (1985) Supraophthalmic carotid infusion for recurrent glioma. Rationale, technique, and preliminary results for cis-platin and BCNU. J. Neurooncol. 3, 5–11.

    Article  PubMed  CAS  Google Scholar 

  175. Fine, H. A. and Antman, K. H. (1992) High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience. Bone Marrow Transplantation 10, 315–321.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tatter, S.B., Harsh, G.R. (1998). Current Treatment Modalities for Brain Tumor. In: Chiocca, E.A., Breakefield, X.O. (eds) Gene Therapy for Neurological Disorders and Brain Tumors. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-478-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-478-8_10

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5314-1

  • Online ISBN: 978-1-59259-478-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics